Autopsy report · NCT02197936

Norwegian Adenomyosis Study III: Peristalsis

“Study was suspended due to organisational difficulties.”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 4 years 6 months before it stopped.
• 3 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Sponsor

Oslo University Hospital

Sponsor type

University, hospital or other

Conditions

Adenomyosis; Infertility; Dysmenorrhea

Participants

3

Sites

1

Countries

Norway

Trials that died the same way

• Sublingual Methadone for the Management of Cancer-related Procedure Pain in Inpatients
  “Study suspended due to low accrual” (78% match in meaning)
• Study of the Safety and Effectiveness of Two Doses of Investigational Study Drug EVP-6124 in Subjects With Alzheimer's Disease
  “Study has been suspended due to clinical hold.” (73% match in meaning)
• ExAblate Blood Brain Barrier Disruption (BBBD) for Planned Surgery in Suspected Infiltrating Glioma
  “Study temporarily suspended until priorities are reassessed” (73% match in meaning)
• Supplementation With Omega-3: Mechanism of Action
  “This study was suspended because there is no more funds to complete the study.” (72% match in meaning)
• An Efficacy and Safety of Flomoxef Versus Cefepime in the Treatment of Participants With Urinary Tract Infections
  “Study was prematurely terminated due to administrative and strategic reasons” (72% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.